The FDA has approved the first condom designed specifically for anal sex.
Anal sex: Food and Drug Administration officials have approved the use of a condom that is particularly developed for anal intercourse, marking the first time this has happened.
Despite the fact that health professionals recommend the use of condoms for all types of sexual encounters, the United States Food and Drug Administration formerly prevented corporations from promoting their products as an effective tool for safe anal sex in the United States. After the Food and Drug Administration stated on Wednesday that it would allow Global Protection Corp. to promote its One Male Condom as a device that “helps prevent transmission of sexually transmitted illnesses” during both vaginal and anal intercourse, the situation has shifted dramatically.
According to the New York Times, experts think that the permission will encourage more individuals to wear condoms during anal intercourse, which “carries the highest risk of HIV transmission” due to “the largest sexual exposure risk.”
In the Center for Devices and Radiological Health’s Office of GastroRenal, ObGyn, General Hospital, and Urology Devices, Courtney Lias, Ph.D., director of the FDA’s Office of GastroRenal, ObGyn, General Hospital, and Urology Devices, said, “The risk of sexually transmitted infection transmission during anal intercourse is significantly higher than the risk of sexual transmission during vaginal intercourse.” “The FDA’s approval of a condom that is explicitly suggested, studied, and labeled for anal intercourse may increase the probability that condoms will be used during anal intercourse,” the agency says. Furthermore, this authorization contributes to our goal of advancing health equality via the development of safe and effective medicines that fit the requirements of a diverse population, which is one of our top priorities. “
According to the New York Times, Global Protection Corp. requested FDA approval for an amendment to its labeling last year, expressly to include anal sex among the condom’s intended uses. The FDA granted approval, and the condom is now available for purchase. Following research, the One Male Condom had a 1.89 percent failure rate for vaginal intercourse and a failure rate of less than 1 percent for anal sex, prompting the business to submit their request for certification. More than 500 males between the ages of 18 and 54 took part in the clinical experiment; 252 of the patients had had sexual relations with other men, and another 252 had sexual relations with women.
